Skip to content

Clinical trials

Phase 2 Diabetes Mellitus trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus Phase: Phase 2 Country / region: Germany Clear all

51 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20041
20062
20073
20085
20091
20102
20112
20122
20135
20141
20158
20161
20172
20186
20191
20202
20223
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed40
Terminated7
Withdrawn2
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S9
Novartis Pharmaceuticals4
Technical University of Munich4
GlaxoSmithKline3
Profil Institut für Stoffwechselforschung GmbH3
AstraZeneca2
Oxurion2
Tris Pharma, Inc.2
AbbVie1
Allergan1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus51
Diabetes Mellitus, Type 218
Diabetes Mellitus, Type 19
Diabetic Nephropathies4
Diabetic Neuropathies4
Diabetic Retinopathy3
Obesity3
Diabetes Complications2
Endocrine System Diseases2
Hypertension2

Trials

Showing 1 to 25 of 51. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.